Clinical Trial Update: Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating memantine for cognitive and MRI volumetric measures in moderate Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: Forest Laboratories | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED